News Archive

MHRA - Risk minimisation measures for medicines Guidance

16th April 2025

Guidance for healthcare professionals on risk minimisation options for medicines.

Read More+

MHRA Blog - MedTech regulatory reform and the importance of partnerships

16th April 2025

Medical technologies will play a critical role in delivering the government’s 10 Year Health Plan and its three shifts: hospital to community; analogue to digital; and sickness to prevention.

Read More+

WHO - WHO Member States conclude negotiations and make significant progress on draft pandemic agreement

16th April 2025

Proposal to be submitted to World Health Assembly in May for consideration

Read More+

MHRA - Clinical Trials regulations signed into law

12th April 2025

12-month roll-out begins today for the biggest regulatory shake up of clinical trials in 20 years

Read More+

EMA - Big Data Highlights April 2025

10th April 2025

Network Data Steering Group quarterly news on data and AI in medicines regulation

Read More+

MHRA - Analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients

10th April 2025

Press release, 9th April 2025

Read More+

MHRA - WHO confirms MHRA to continue playing vital role in ensuring the quality of global biological medicines

10th April 2025

News story, 9th April 2025

Read More+

EMA - CTIS Designated as a Primary Registry

3rd April 2025

by WHO

Read More+

MHRA - Blog Post by Dame June Raine

1st April 2025

How innovations are transforming regulation and speeding new treatments to healthcare

Read More+

MHRA - MHRA showcases next phase of regulatory science to bring innovative treatments to patients sooner

1st April 2025

Last week, the Medicines and Healthcare products Regulatory Agency (MHRA) hosted an event for the seven newly established Centres of Excellence for Regulatory Science and Innovation June Raine, MHRA Chief Executive, said: “At our CERSIs event this week, the depth of expertise was impressive and there was real excitement about the progress being made. The discussions highlighted a strong commitment to improving access to innovation for patients, shared with our partners Innovate UK, Office of Life Sciences and the MRC. Through the CERSIs, we have a major opportunity to drive advances in regulatory science in the UK – now is the time to turn that potential into action.”

Read More+